Experimental drug reverses paralysis and vision loss in multiple sclerosis model
11 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Experimental drug reverses paralysis and vision loss in multiple sclerosis model" is generating significant coverage in the Health category, with 11 articles from 11 distinct sources tracked by PULSE so far.
Outlets currently covering the story include National Institutes of Health (NIH) | (.gov), WSVN, NR Times and Yahoo. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 45d ago.
Quick answers
Why is "Experimental drug reverses paralysis and vision loss in multiple sclerosis model" trending?
Because 11 independent news sources published 11 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (11)
- Modified HIV drug reverses vision loss and paralysis in multiple sclerosis model National Institutes of Health (NIH) | (.gov) · 50d ago
- Experimental MS drug reverses vision loss, paralysis in mice, study finds WSVN · 50d ago
- Experimental drug reverse MS paralysis and vision loss NR Times · 50d ago
- Modified HIV drug could reverse vision loss, paralysis from MS, study suggests Yahoo · 50d ago
- Modified HIV drug could reverse vision loss, paralysis from MS, study suggests FOX 10 Phoenix · 50d ago
- Modified HIV drug could reverse vision loss, paralysis from MS, study suggests LiveNOW from FOX · 50d ago
- Experimental Drug Shows Nerve Repair in Mice Legal Reader · 50d ago
- Experimental Drug Could Reverse Multiple Sclerosis Damage Inside Precision Medicine · 50d ago
- Experimental UVA Drug Reversed Paralysis and Vision Loss in Mice with MS-Like Disease, but Human Trials Still Needed Medical Daily · 50d ago
- Modified HIV Drug Reverses MS Vision Loss, Paralysis Mirage News · 50d ago
- Experimental drug reverses paralysis and vision loss in multiple sclerosis model Medical Xpress · 50d ago
Topics
Related trends
Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials
Eli Lilly's experimental triple-hormone drug retatrutide cut knee osteoarthritis pain and produced average weight loss of roughly 25% in two Phase 3 trials involving more than 1,000 adults with obesity.
Experimental drug shows 'phenomenal' results fighting California's Valley fever
An experimental antifungal drug is showing 'phenomenal' results in treating patients with California's Valley fever, including refractory cases.
Experimental pancreatic cancer vaccine shows promise in clinical trial
Recent coverage highlights an experimental pancreatic cancer vaccine showing promise in a clinical trial.
NASA Announces X-70 "Fractal" Experimental Aircraft
1 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
Experimental evidence of altermagnetism in a layered material opens a promising path toward future spintronics
A layered crystal shows experimental altermagnetism, a third magnetic state poised to reshape spintronic technology.
Experimental Lilly combination drug tops Zepbound in weight-loss trial
An experimental combination drug from Eli Lilly outperforms Zepbound in a new weight-loss trial.